Cardiopulmonary and hematological effects of infrared LED photobiomodulation in the treatment of SARS-COV2

• Published in: Journal of photochemistry and photobiology. B, Biology Vol. 238; p. 112619
• Main Authors: Pereira, Pâmela Camila, de Lima, Carlos José, Fernandes, Adriana Barrinha, Zângaro, Renato Amaro, Villaverde, Antonio Balbin
• Format: Journal Article
• Language: English
• Published: Switzerland Elsevier B.V 01.01.2023; Published by Elsevier B.V
• Subjects: Cardiopulmonary functions; COVID-19; COVID-19 Drug Treatment; Hemogram; Humans; Lung; Near-infrared LED; Photobiomodulation; RNA, Viral; SARS-CoV-2; SARS-COV2; Hemogram; SARS-COV2; Cardiopulmonary functions; Photobiomodulation; Near-infrared LED
• ISSN: 1011-1344; 1873-2682
• DOI: 10.1016/j.jphotobiol.2022.112619

COVID-19 disease is caused by SARS-CoV-2 which can trigger acute respiratory syndrome, which presents with dense alveolar and interstitial infiltrates and pulmonary edema, causing severe hypoxemia and significant alteration to pulmonary mechanics with reduced pulmonary compliance. The photobiomodulation technique alters cellular and molecular metabolism, showing promising results regarding the reduction of acute pulmonary inflammation. To compare the photomodulation technique using near-infrared LED to conventional respiratory physiotherapy treatment in patients with COVID-19 in reversing acute conditions, reducing hospitalization time, and decreasing the need for oxygen therapy. The cohort was comprised of 30 patients undergoing COVID-19 treatment who were divided and allocated into two equal groups randomly: the LED group (LED), treated with infrared LED at 940 nm and conventional therapy, and the control group (CON), who received conventional treatment (antibiotic therapy for preventing superimposed bacterial infections, and physiotherapy) with LED irradiation off. Phototherapy used a vest with an array of 300 LEDs (940 nm) mounted on a 36 cm × 58 cm area and positioned in the patient's anterior thoracic and abdominal regions. The total power was 6 W, with 15 min irradiation time. Cardiopulmonary functions and blood count were monitored before and after treatment. The patients were treated daily for 7 days. Statistical analysis was conducted using a two-tailed unpaired Student's t-test at a significance level of α = 0.05. Post-treatment, the LED group showed a reduction in hospital discharge time and a statistically significant improvement for the following cardiopulmonary functions: Partial Oxygen Saturation, Tidal Volume, Maximum Inspiratory, and Expiratory Pressures, Respiratory Frequency, Heart Rate, and Systolic Blood Pressure (p < 0.05). Regarding blood count, it was observed that post-treatment, the LED group presented with significant differences in the count of leukocytes, neutrophils, and lymphocytes. Photobiomodulation therapy can be used as a complement to conventional treatment of COVID-19, promoting the improvement of cardiopulmonary functions, and minimization of respiratory symptoms. •A vest with an array of infrared LEDs was used for treatment of COVID-19 patients.•Photobiomodulation with infrared LED reduced hospitalization time for COVID-19.•Infrared LED photobiomodulation promotes improvement of cardiopulmonary functions.•Minimized symptoms of COVID-19 patients.•Photobiomodulation therapy can be used as an adjunct in the treatment in COVID-19.